|
|
MedaSorb Technologies Corporation Reports Full Year 2009 Financial Results - MarketWatch (press release) |
|
MarketWatch (press release)As blood is pumped through the CytoSorb(TM) cartridge using standard dialysis equipment, the beads bind and remove cytokines and other toxins from blood. ... |
|
|
Gilead Initiates Phase III Clinical Program Evaluating Single-Tablet, Once ... - MarketWatch (press release) |
|
MarketWatch (press release)Renal impairment, including cases of acute renal failure and Fanconi syndrome (renal tubular injury with severe hypophosphatemia), has been reported in ... |
|
Affymax Names John A. Orwin President and Chief Operating Officer - MarketWatch (press release) |
|
MarketWatch (press release)... as we prepare for commercialization of Hematide(TM)/peginesatide for the treatment of anemia in chronic renal failure patients," said Arlene Morris. ... |
|
NxStage expands hemodialysis supply deal - Mass Device |
|
Mass DeviceNxStage Medical Inc. expands its deal with Renal Advantage Inc. to provide hemodialysis supplies to another 43 dialysis centers. ...NxStage(R) Expands Streamline(R) Blood Tubing Set and MasterGuard(R) Needle ... |
|
Haiti: Three Months After the Earthquake - Doctors Without Borders |
|
Doctors Without BordersNephrology: After assisting at the Port-au-Prince General Hospital in the days after the earthquake, helping to treat crush injuries and chronic cases, ... |
|
|
|
|
<< Start < Prev 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 Next > End >>
|
|
Page 1666 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
